Health Systems News and Research

RSS

HPV infections continue after age 27, so who is still at risk?

HPV infections in women aged 27+ highlight the need for updated vaccination policies, emphasizing ongoing risk and the importance of preventive healthcare.

30 Apr 2026

WHO validates Australia for eliminating trachoma as public health problem

The World Health Organization (WHO) has validated Australia for eliminating trachoma as a public health problem, marking a significant milestone in the health of Indigenous peoples and in global efforts to combat neglected tropical diseases (NTDs).

29 Apr 2026

New genetic risk test estimates inherited risk for cardiovascular conditions

Researchers at Mass General Brigham Heart and Vascular Institute and collaborators have developed and validated a new genetic risk test that can estimate a person's inherited risk for eight common cardiovascular conditions, offering a more comprehensive approach to prevention.

29 Apr 2026

PCORI announces new funding for patient-centered clinical effectiveness research

The Patient-Centered Outcomes Research Institute (PCORI) today announced new funding to support patient-centered comparative clinical effectiveness research (CER) across a range of health conditions experienced by Americans, along with projects designed to help bring practice-changing CER results into real-world care settings.

28 Apr 2026

WHO report shows measurable progress in reducing global hepatitis infections

Global efforts to combat viral hepatitis are delivering measurable progress in reducing infections and deaths, but the disease remains a major global health challenge, according to a new World Health Organization (WHO) report released today at the World Hepatitis Summit.

28 Apr 2026

Twice-yearly blood pressure treatment could reshape hypertension care, but doctors warn against a “fire-and-forget” approach

Long-acting RNA interference therapy for hypertension could shift blood pressure control from daily pill-taking to scheduled, system-led protection. But the authors warn that this “vaccine-like” model must preserve lifestyle support, monitoring, and follow-up to avoid clinical disengagement.

27 Apr 2026

American Heart Association backs innovators advancing equitable health solutions

Cardiovascular disease remains the leading cause of death in the United States and drives nearly $415 billion in annual health‑related costs, according to the American Heart Association, highlighting the need for scalable, real‑world health innovation.

24 Apr 2026

Trends reveal growing burden of deaths from non-ischemic cardiogenic shock

New data from the CDC WONDER database finds deaths from heart attack-related cardiogenic shock (CS) decreased between 1999 and 2020, but deaths linked to heart failure (HF) and abnormal heart rhythms have risen sharply since 2010, particularly among men.

24 Apr 2026

The Big Catch-Up reaches millions of children with life-saving vaccines

The Big Catch-Up (BCU), a historic multi-year, multi-country effort to address vaccination declines driven largely by the COVID-19 pandemic, has reached an estimated 18.3 million children aged 1 to 5 across 36 countries with more than 100 million doses of life-saving vaccines, helping to narrow critical immunity gaps, announced Gavi, the Vaccine Alliance (Gavi), WHO, and UNICEF at the start of World Immunization Week.

24 Apr 2026

Virtual neurology visits match in-person care outcomes

For people who see a neurology clinician for the first time, a new study has found that being seen virtually vs. in-person made no difference in how soon they needed more care.

22 Apr 2026

Paxlovid speeds recovery but does not reduce severe COVID outcomes in vaccinated adults

Paxlovid (nirmatrelvir-ritonavir) does not reduce hospital admissions or deaths in vaccinated adults at higher risk of severe COVID-19, despite helping them recover faster, according to results from two national trials published today in the New England Journal of Medicine.

22 Apr 2026

Tirzepatide vs. semaglutide: Study compares cost and health outcomes in obesity

In a US societal-perspective lifetime simulation based on SURMOUNT-5 data, tirzepatide was projected to deliver lower total costs and better health outcomes than semaglutide for adults with obesity or overweight without type 2 diabetes.

22 Apr 2026

Simple chair-rise test signals future health risks in seniors

How easily older adults can stand up from a chair may be a telling indicator of their overall quality of life.

21 Apr 2026

New research calls for improved pediatric burn care infrastructure nationwide

The UCI Health Regional Burn Center is one of the only burn centers in Orange County equipped to treat the most complex burn patients 24 hours a day, including children.

21 Apr 2026

High immune cell ratios may predict future Alzheimer's disease risk

Circulating white blood cells called neutrophils are some of the immune system's first responders. Their numbers shoot up during infection and inflammation, shifting the ratio of neutrophils to other types of immune cells in the blood.

21 Apr 2026

Long-term exposure to air pollution (PM2.5) raises risk of developing cancer by 11 % and of dying from cancer by 12 %

The Union for International Cancer Control (UICC), with support from the Clean Air Fund, has released a global report, Clean air in cancer control: An overview of the evidence, presenting data on the scale of cancer risk and mortality from polluted air.

21 Apr 2026

Why Japan saw a major pertussis surge in 2025 while other countries peaked earlier

This study found that pertussis cases fell across Japan, Australia, New Zealand, China, and the USA during COVID-19 restrictions, then resurged afterward, with most countries peaking in 2024 but Japan showing a delayed major outbreak in 2025. In Japan, the surge was concentrated in school-aged children and adolescents, highlighting possible gaps in booster protection and the need to reassess immunization strategies.

20 Apr 2026

Proteomics and AI bring earlier risk prediction into sharper focus

This review examines how high-throughput proteomics is expanding precision medicine by improving biomarker discovery, disease prediction, and drug development. It also shows how AI is helping researchers interpret complex proteomic data while highlighting major barriers such as standardization, validation, and clinical translation.

19 Apr 2026

Therapy access could tackle joblessness

Expanding access to NHS Talking Therapies may help reduce the long-term economic inactivity faced by people with entrenched mental health problems, University of Manchester researchers say.

17 Apr 2026

Fast answers and extra research drive AI healthcare use in America

One in four U.S. adults - the equivalent of over 66 million Americans - report having used artificial intelligence tools or chatbots for physical or mental healthcare information or advice, according to new research released today from the West Health-Gallup Center on Healthcare in America.

17 Apr 2026